Professor David Shreiber has been selected to receive a Leaders in Faculty Diversity Award for 2019-2020 by the Rutgers Committee to Advance Our Common Purposes, which has representation from students, staff, and faculty across all regions of the university. The committee's mission is to promote the development of a university community that values and advances diversity and inclusion.
News
February 2020
February 25, 2020
BME PhD student Mary Pat Reiter has been awarded a $5,000 STLE (Society of Tribologists and Lubrication Engineers) Elmer E. Klaus 2020 Fellowship. It is an award offered by the national chapter to one graduate student based on the quality of a research proposal, their academic performance, and a recommendation letter. She will be honored during STLE’s 75th Annual Meeting & Exhibition, May 3-7 2020, at the Hyatt Regency hotel in Chicago.
February 5, 2020
First clinical trial of an automated blood drawing and testing device
February 5, 2020
In the future, robots could take blood samples, benefiting patients and healthcare workers alike.
A Rutgers-led team has created a blood-sampling robot that performed as well or better than people, according to the first human clinical trial of an automated blood drawing and testing device.
The device provides quick results and would allow healthcare professionals to spend more time treating patients in hospitals and other settings.
January 2020
January 29, 2020
The National Institutes of Health has awarded a two-year, $420,025 grant to Professor Charles Roth for an R21 project entitled "Surface Active Polyelectrolyte Nanomedicine for Treatment of Lung Infections in Cystic Fibrosis." The goal of the project is to develop aerosolized nanomedicines that can penetrate mucus and biofilms in the lungs of cystic fibrosis patients for improved delivery and antibiotic efficacy.
January 22, 2020
Professor Joseph Freeman was awarded a patent for his technology, "Three-dimensional pre-vascularized scaffold for bone regeneration." Former students Brittany Taylor and Pushpendra Patel are co-authors.
January 22, 2020
The New Jersey Health Foundation has awarded a $35,000 research grant to Professor David Shreiber to study vascular Ehlers-Danlos syndrome using a tissue engineering approach. vEDS is a genetic connective tissue disorder caused by mutations in the gene that produces type-III collagen.
December 2019
December 12, 2019
A patent was issued to Professors Martin Yarmush and Francois Berthiaume entitled, " In Vitro Model of Macrosteatotic (Fatty) Liver” (US Patent number: 10495631). The invention describes a system and methods for identifying compounds for defatting and functional recovery of macrosteatotic hepatocytes. Other Rutgers inventors include Nir Nativ, Gabriel Yarmush, Tim Maguire, and Rene Schloss.
December 11, 2019
BME PhD graduate student Erika Davidoff and master’s student Pragya Hooda are among three finalists from Rutgers to present their research at the upcoming annual J&J Engineering Showcase in February 2020. Erika’s poster is titled “Self-Healing Coatings for Improving Brain Implant Biocompatibility” and her PI is Professor Jay Sy. Pragya’s poster is titled “Microfluidic Spectrophotometer for Drug Monitoring in Tuberculosis Patients” and her PI is Professor Umer Hassan.
December 10, 2019
Rutgers-led team pioneers automated way to make unique materials with polymers
December 4, 2019
A Rutgers-led team of engineers has developed an automated way to produce polymers, making it much easier to create advanced materials aimed at improving human health.
The innovation is a critical step in pushing the limits for researchers who want to explore large libraries of polymers, including plastics and fibers, for chemical and biological applications such as drugs and regenerative medicine through tissue engineering.
December 10, 2019
Professor Francois Berthiaume, together with Professor Melitta Schachner from the W. M. Keck Center for Collaborative Neuroscience, and Dr. Suneel Kumar, a Research Associate in Dr. Berthiaume's laboratory, were awarded a 2-year, $200,000 award from the New Jersey Commission on Spinal Cord Research (NJCSCR) to develop new protein therapeutics to promote functional repair of the damaged spinal cord.